BRPI0821129A2 - Métodos para a inibição de cicatrização - Google Patents

Métodos para a inibição de cicatrização

Info

Publication number
BRPI0821129A2
BRPI0821129A2 BRPI0821129-9A BRPI0821129A BRPI0821129A2 BR PI0821129 A2 BRPI0821129 A2 BR PI0821129A2 BR PI0821129 A BRPI0821129 A BR PI0821129A BR PI0821129 A2 BRPI0821129 A2 BR PI0821129A2
Authority
BR
Brazil
Prior art keywords
methods
healing
inhibition
healing inhibition
Prior art date
Application number
BRPI0821129-9A
Other languages
English (en)
Inventor
Mark Willian James Ferguson
Sharon O'kane
Nicholas Occleston
Kerry Nield
Adam Boanas
James Bush
Nicholas Goldspink
Abdul Sattar
Kate Owen
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of BRPI0821129A2 publication Critical patent/BRPI0821129A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0821129-9A 2007-12-12 2008-12-11 Métodos para a inibição de cicatrização BRPI0821129A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0724231.6A GB0724231D0 (en) 2007-12-12 2007-12-12 Methods for inhibiting scarring
PCT/GB2008/004081 WO2009074797A1 (en) 2007-12-12 2008-12-11 Methods for inhibiting scarring

Publications (1)

Publication Number Publication Date
BRPI0821129A2 true BRPI0821129A2 (pt) 2015-06-16

Family

ID=39048052

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821129-9A BRPI0821129A2 (pt) 2007-12-12 2008-12-11 Métodos para a inibição de cicatrização

Country Status (10)

Country Link
US (1) US20100266532A1 (pt)
EP (1) EP2231178A1 (pt)
JP (1) JP2011506414A (pt)
CN (1) CN101951941A (pt)
AU (1) AU2008334412A1 (pt)
BR (1) BRPI0821129A2 (pt)
CA (1) CA2709007A1 (pt)
GB (1) GB0724231D0 (pt)
WO (1) WO2009074797A1 (pt)
ZA (1) ZA201004724B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
NZ601660A (en) 2008-08-25 2014-05-30 Excaliard Pharmaceuticals Inc Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
US8946172B2 (en) * 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
EP2582386A2 (en) * 2010-06-16 2013-04-24 Allergan, Inc. Il-10 and methods of treating ocular and other diseases
KR101697396B1 (ko) 2011-02-02 2017-01-17 엑스칼리아드 파마슈티컬즈, 인코포레이티드 결합 조직 성장 인자（ctgf）를 표적으로 하는 안티센스 화합물을 사용하여 켈로이드 또는 비후성 흉터를 치료하는 방법
AU2013286812B2 (en) 2012-07-04 2017-04-20 Zz Biotech Llc Treatment of inflammatory skin disorders
CN102836424B (zh) * 2012-09-25 2014-03-19 中国人民解放军第四军医大学 一种预防及治疗瘢痕的疫苗及制备方法
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
ES2688206T3 (es) 2013-06-17 2018-10-31 Armo Biosciences, Inc. Procedimiento de evaluación de la identidad y la estabilidad de proteínas
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
EP3068425B1 (en) 2013-11-11 2021-01-27 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
PL3131572T3 (pl) 2014-04-16 2022-02-07 Zz Biotech Llc Analog apc do zastosowania w zaleczaniu rany
PT3137102T (pt) * 2014-04-16 2021-09-28 Zz Biotech Llc Apc para utilização no tratamento de cicatrização cutânea anormal
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
CA2986755A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
US10398761B2 (en) 2015-08-25 2019-09-03 Armo Biosciences, Inc. Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers
CA3079844A1 (en) * 2017-11-10 2019-05-16 Armo Biosciences, Inc. Compositions and methods of use of interleukin-10 in combination with immune checkpoint pathway inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
GB2304045A (en) * 1995-08-04 1997-03-12 Univ Manchester Betaglycan compositions for promoting the healing of wounds and fibrotic diseases
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
US20020025316A1 (en) * 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
GB2306481A (en) * 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
EP1806131A3 (en) * 1996-07-22 2007-08-01 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders
DE69716460T2 (de) * 1996-12-04 2003-06-26 Renovo Ltd., Manchester Wundheilung und behandlung von fibrose
GB0217136D0 (en) * 2002-07-24 2002-09-04 Renovo Ltd Wound healing & treatment of fibrosis
GB0607774D0 (en) * 2006-04-20 2006-05-31 Renovo Group Plc Medicaments

Also Published As

Publication number Publication date
CA2709007A1 (en) 2009-06-18
WO2009074797A8 (en) 2010-09-02
ZA201004724B (en) 2011-09-28
WO2009074797A1 (en) 2009-06-18
CN101951941A (zh) 2011-01-19
AU2008334412A1 (en) 2009-06-18
GB0724231D0 (en) 2008-01-30
US20100266532A1 (en) 2010-10-21
EP2231178A1 (en) 2010-09-29
JP2011506414A (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
BRPI0821129A2 (pt) Métodos para a inibição de cicatrização
CY2017016I2 (el) Αναστολεις πρωτεασωματος
BRPI0813903A2 (pt) Processos para a prepração de pirazóis
BRPI0721502A2 (pt) Método para tratamento de uma formação fraturada
EP2131749A4 (en) Surgical stapling apparatus
BRPI0812164A2 (pt) Técnicas para provisão automática de software
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0819568A2 (pt) métodos para a preparação de um composto
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
PT3106873T (pt) Método para a deteção de cancro
BRPI1008664A2 (pt) comprimidos para a terapia de combinação
BRPI0814706A2 (pt) Meios para remoção de compostos orgânicos
PT2223114T (pt) Calibrante para imunoensaios
EP2177529A4 (en) NEW SECRETASE HEMMER
BRPI0815415A2 (pt) Marcador preditivo para tratamento inibidor de egfr
ATE522533T1 (de) Pyrazolopyrimidinonkinaseinhibitor
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
BRPI0715729A2 (pt) inibidores para glyt-1
BRPI0821270A2 (pt) Métodos para a inibição de cicatrização
ES1064720Y (es) Guia para persiana
FI20075320A0 (fi) Uusia käyttökelpoisia inhibiittoreita
ES1065835Y (es) Caperuza para cetreria
ES1067107Y (es) Entresuela para calzado
ES1064647Y (es) Complemento para cepillos de dientes
ES1063735Y (es) Testero para persiana

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.